表現TrkA融合蛋白質的神經退化基因轉殖動物
- 經濟部產業技術司–專利資料集 @ 經濟部
專利名稱-中文表現TrkA融合蛋白質的神經退化基因轉殖動物的核准國家是美國, 執行單位是工研院生醫所, 產出年度是97, 專利性質是發明, 計畫名稱是類新藥技術開發計畫, 專利發明人是蔡元彰 黃崇雄 吳幸綿 陳燕春 蘇珍儀 胡璨麟, 證書號碼是7,342,146.
序號 | 4709 |
產出年度 | 97 |
領域別 | (空) |
專利名稱-中文 | 表現TrkA融合蛋白質的神經退化基因轉殖動物 |
執行單位 | 工研院生醫所 |
產出單位 | (空) |
計畫名稱 | 類新藥技術開發計畫 |
專利發明人 | 蔡元彰 黃崇雄 吳幸綿 陳燕春 蘇珍儀 胡璨麟 |
核准國家 | 美國 |
獲證日期 | (空) |
證書號碼 | 7,342,146 |
專利期間起 | (空) |
專利期間訖 | (空) |
專利性質 | 發明 |
技術摘要-中文 | The present invention provides a neurodegenerative, non-human transgenic mammal whose cells contain a recombinant DNA sequence (the TrkA-hFc transgene) for encoding at least a TrkA fusion protein or a defective TrkA receptor. The transgenic mammal provided by this invention can be useful as models for disease and for identifying agents that modulate gene expression and gene function, and as potential treatments for various disease states and disease conditions. As embodied and broadly described herein, the transgenic mammal provided by this invention is useful for studies on neurotrophins and also useful for identifying agents or compounds that modulate the biological functions of a Trk receptor, including the screening and identification of potential therapeutic agents or compounds. |
技術摘要-英文 | (空) |
聯絡人員 | 李露蘋 |
電話 | 03-59117812 |
傳真 | 03-5917431 |
電子信箱 | oralp@itri.org.tw |
參考網址 | http://www.patentportfolio.itri.org.tw |
備註 | 0 |
特殊情形 | (空) |
同步更新日期 | 2023-07-05 |
序號4709 |
產出年度97 |
領域別(空) |
專利名稱-中文表現TrkA融合蛋白質的神經退化基因轉殖動物 |
執行單位工研院生醫所 |
產出單位(空) |
計畫名稱類新藥技術開發計畫 |
專利發明人蔡元彰 黃崇雄 吳幸綿 陳燕春 蘇珍儀 胡璨麟 |
核准國家美國 |
獲證日期(空) |
證書號碼7,342,146 |
專利期間起(空) |
專利期間訖(空) |
專利性質發明 |
技術摘要-中文The present invention provides a neurodegenerative, non-human transgenic mammal whose cells contain a recombinant DNA sequence (the TrkA-hFc transgene) for encoding at least a TrkA fusion protein or a defective TrkA receptor. The transgenic mammal provided by this invention can be useful as models for disease and for identifying agents that modulate gene expression and gene function, and as potential treatments for various disease states and disease conditions. As embodied and broadly described herein, the transgenic mammal provided by this invention is useful for studies on neurotrophins and also useful for identifying agents or compounds that modulate the biological functions of a Trk receptor, including the screening and identification of potential therapeutic agents or compounds. |
技術摘要-英文(空) |
聯絡人員李露蘋 |
電話03-59117812 |
傳真03-5917431 |
電子信箱oralp@itri.org.tw |
參考網址http://www.patentportfolio.itri.org.tw |
備註0 |
特殊情形(空) |
同步更新日期2023-07-05 |